Phase III Long-term Study and Comparative Clinical Study of Nipradilol Ophthalmic Solution in Patients with Primary Open-angle Glaucoma and Ocular Hypertension

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 12, 2006, Pages 729-734

  Kanno, Mikiko ^a   Araie, Makoto ^a   Masuda, Kanjiro ^a   Takase, Masahiro ^b   Kitazawa, Yoshiaki ^c   Shiose, Yoshihiko ^d   Azuma, Ikuo ^e   Ogawa, Nobuya ^f   Ohdo, Shigehiro ^g  

^a UNIVERSITY OF TOKYO   (Japan)

^b Mishuku Hospital   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d Shiose Eye Clinic   (Japan)

^e OSAKA MEDICAL COLLEGE   (Japan)

^f EHIME UNIVERSITY   (Japan)

^g KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CAS 81486 22 8; CAS 91524 16 2; NIPRADILOL; TIMOLOL;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG STRUCTURE; DRUG USE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TACHYPHYLAXIS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROPANOLAMINES; TIMOLOL; VASODILATOR AGENTS;

EID: 33845399118     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296793     Document Type: Article

References (24)

1. Uchida, Y., Nakamura, M., Shimizu, S. et al., Vasoactive and Beta-adrenoceptor Blocking Properties of 3, 4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopy-ran (K-351), a New Antihypertensive Agent. Arch. Int. Phar-macodyn. Ther. 262, 132 (1983)
2. Ohira, A., Wada, Y., Fujii, M. et al., Effects of Nipradilol (K-351) on Alpha-adrenoceptor Mediated Responses in Various Isolated Tissues. Arch. Int. Pharmacodyn. Ther. 278, 61 (1985)
3. Shirasawa, Y., Fujii, M., Nakamura, M., Vasodilating Action of Nipradilol (K-351) in the Pithed Rat Pretreated with Dihydroergotamine. Jpn. J. Pharmacol. 39, 77 (1985)
4. Okamura, T., Kitamura, Y., Uchiyama, M. et al., Canine Retinal Arterial and Arteriolar Dilatation Induced by Nipradilol, a Possible Glaucoma Therapeutic. Pharmacology 53, 302 (1996)
5. Furuta, Y., Sano, H., Effects of Nipradilol on Ambulatory Blood Pressure of Essential Hypertensive Patients. Ther. Res. 15, 379 (1994)
6. Mori, M., Araie, M., A Simple Methods of Determining the Time Course of Timololʼns Effects on Aqueous Flow in Humans. Arch. Ophthalmol. 109, 1099 (1991)
7. Oshika, T., Araie, M., Sugiyama, T. et al., Effect of Bunazosin Hydrochloride on Intraocular Pressure and Aqueous Humor Dynamics in Normotensive Human Eyes. Arch. Ophthalmol. 109, 1569 (1991)
8. Nathanson, J., NItrovasodilator as a New Class of Ocular Hypotensive Agents. J. Pharmacol. Exp. Ther. 260, 956 (1991)
9. Sugiyama, T., Tokuoka, S., Nakajima, M. et al., Changes in Rabbit Choroidal Capillary Blood Flow and Corneal Temperature with Topically Applied UF-021, Bunazosin Hydrochloride and Propranolol Hydrochloride. J. Eye 9, 1430 (1992)
10. Luksch, A., Polak, K., Beier, C. et al., Effects of Systemic NO Synthase Inhibition on Choroidal and Optic Nerve Head Blood Flow in Healthy Subjects. Invest. Ophthalmol. Vis. Sci. 41, 3080 (2000)
11. Koss, M., Functional Role of Nitric Oxide in Regulation of Ocular Blood Flow Eur. J. Pharmacol. 374, 161 (1999)
12. Kanno, M., Araie, M., Tomita, K. et al., Effects of Topical Nipradilol, a Beta-blocking Agent with Alpha-blocking and Nitroglycerin-like Activities, on Aqueous Humor Dynamics and Fundus Circulation. Invest. Ophthalmol. Vis. Sci. 39, 736 (1998)
13. Kanno, M., Araie, M., Koibuchi, H. et al., Effects of Topical Nipradilol, a Beta Blocking Agent with Alpha Blocking and Nitroglycerin-like Activities, on Intraocular Pressure and Aqueous Dynamics in Humans. Br. J. Ophthalmol. 84, 293 (2000)
14. Masuda, K., Shirato, S., Araie, M. et al., Early Phase II Clinical Trial of KT-210 (Nipradilol Ophthalmic Solution) in Ocular Hypertension. J. Clin. Therap. Med. 12, 3011 (1996)
15. Le Jeunne, C., Munera, Y., Hugues, F. C., Systemic Effects of Three Beta-blocker Eyedrops: Comparison in Healthy Volunteers of Beta 1-and Beta 2-adrenoreceptor Inhibition. Clin. Pharmacol. Ther. 47, 578 (1990)
16. Brooks, A. M. V., Gilled, W. E., Ocular Beta-blockers in Glaucoma Management; Clinical Pharmacological Aspects. Drugs Ageing 2, 208 (1992)
17. Jay, J. L., Cardiac Side Effects of Beta Blocker Eyedrops. Br. J. Ophthalmol. 72, 240 (1988)
18. Hugues, F. C., Matte, J. C., Le Jeunne, C. et al., Effects of Beta-adrenoceptors Blocking Eye Drops in Patients with Chronic Bronchitis. Therapie 47, 211 (1992)
19. Nelson, W. L., Fraunfelder, F. T., Sills, J. M. et al., Adverse Respiratory and Cardiovascular Events Attributed to Timolol Ophthalmic Solution, 1978-1985. Am. J. Ophthalmol. 102, 606 (1986)
20. Prince, D. S., Carliner, N. H., Respiratory Arrest Following First Dose of Timolol Ophthalmic Solution. Chest 84, 640 (1983)
21. Odeh, M., Oliven, A., Bassan, H., Timolol Eeyedrop-in-duced Fatal Bronchospasm in an Asthmatic Patient. J. Fam. Pract. 32, 97 (1991)
22. Scriabine, A., Torchiana, M. L., Stavoriski, J. M. et al., Some Cardiovascular Effects of Timolol, a New Öz-adrenergic Blocking Agent. Arch. Int. Pharmacodyn. Ther. 205, 76 (1973)
23. Zimmerman, T. J., Kooner, K. S., Kandarakis, A. S. et al., Improving the Therapeutic Index of Topically Applied Ocular Drugs. Arch. Ophthalmol. 102, 551 (1984)
24. Araie, M., Oshika, T., Mori, M. et al., Phase I Study of KT-210 (Nipradilol Ophthalmic Solution): Single Administration Study Jpn. Pharmacol. Ther. 24 (Suppl. 8), S-1177 (1996)